Why David Einhorn’s Greenlight prefers this tiny biotech over AI ‘excitement’By Mario Cazombo / October 22, 2025 Greenlight Capital’s third-quarter investor letter had almost nothing good to say about the hot AI trend, but it does have faith in a tiny biotech.
Book Review: The Financial Restructuring Tool Set August 6, 2025 / Book Reviews, Corporate Finance, Drivers of Value, Economics, Financial Statement Analysis, General
